Already a member? Sign in
Fosamprenavir is a protease inhibitor antiretroviral agent used in the treatment of HIV infections in combination with at least two other antiretroviral agents.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| HIV (Human Immunodeficiency Virus) | 20 | 4 |
|
||||
| Fatigue | 1 | 0 |
See all 23 patients currently taking Fosamprenavir
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Doctor's advice | 4 | ||
| Side effects too severe | 4 | ||
| Other | 3 | ||
| Personal research | 1 | ||
| Not indicated | 1 |
Adherence
Taking treatment as prescribed
Adherence of Fosamprenavir
Always |
3 | 75% |
|
|---|---|---|---|
Usually |
1 | 25% |
|
Sometimes |
0 | 0% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Fosamprenavir
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
0 | 0% |
|
A little |
2 | 50% |
|
Not at all |
2 | 50% |
|
Cost
Paid out of pocket
Cost of Fosamprenavir
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
1 | 33% |
|
< $25 |
2 | 67% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 11, 2012.